![J.C. Lopez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
J.C. Lopez
Direktor/Vorstandsmitglied bei Stablix, Inc.
Ursprung des Netzwerks ersten Grades von J.C. Lopez
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Stablix, Inc.
![]() Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
Pionyr Immunotherapeutics, Inc.
![]() Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA.
6
| Subsidiary | Biotechnology | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von J.C. Lopez
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Versant Venture Management LLC
![]() Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
858 Therapeutics, Inc.
![]() 858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
Thayer School of Engineering At Dartmouth | College/University | Director/Board Member Doctorate Degree | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
FirstLight Bio, Inc. | Director/Board Member President | ||
Avitide, Inc.
![]() Avitide, Inc. BiotechnologyHealth Technology Avitide, Inc. develops affinity purification solutions. Its technology enables development of chromatography resins via chemical synthesis which are not based on costly recombinant proteins. The company was founded by Errik B. Anderson, Warren Kett, Tillman U. Gerngross, Kevin Isett and Jonathan Sheller in 2012 and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member Director/Board Member | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
THE MEDICINES COMPANY | Pharmaceuticals: Major | President Consultant / Advisor | |
OYSR POIN | Pharmaceuticals: Major | Chairman Director/Board Member | |
Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
University of Massachusetts Lowell | College/University | Undergraduate Degree | |
BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Korro Bio, Inc.
![]() Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
SpyGlass Pharma Inc
![]() SpyGlass Pharma Inc Miscellaneous Commercial ServicesCommercial Services Spyglass Ophthalmics, Inc. develops products for vision and eye care. The company was founded by Malik Y. Kahook and Glenn Sussman and is headquartered in Mission Viejo, CA. | Miscellaneous Commercial Services | Director/Board Member | |
AC IMMUNE SA | Pharmaceuticals: Major | Chairman | |
CODIAK BIOSCIENCES | Pharmaceuticals: Major | Chief Executive Officer | |
OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Cytoimmune Therapeutics, Inc.
![]() Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
New Enterprise Associates LLC
![]() New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | Investment Managers | Corporate Officer/Principal | |
Tune Therapeutics, Inc.
![]() Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | Pharmaceuticals: Major | Director/Board Member | |
University of Pennsylvania Medical Center | College/University | Doctorate Degree | |
REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Launchpad Therapeutics, Inc.
![]() Launchpad Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Launchpad Therapeutics, Inc. develops novel therapeutics. | Miscellaneous Commercial Services | Director/Board Member | |
Nexo Therapeutics, Inc.
![]() Nexo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexo Therapeutics is a small molecule oncology company that focuses on discovering and developing new drugs for cancer patients who do not have effective treatments. The company is based in Littleton, CO and Watertown, MA. The company uses covalent ligand discovery, chemical biology, cancer biology, and medicinal chemistry to target the underlying causes of cancer through innovative methods. Nexo Therapeutics was founded by John Athanosopoulos, Andrew J. Phillips, Michael Kim, and Rhamy Zeid. Andrew J. Phillips has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ARCELLX, INC. | Biotechnology | Director/Board Member | |
Morgan Stanley Venture Partners
![]() Morgan Stanley Venture Partners Investment ManagersFinance Morgan Stanley Venture Partners (MSVP) is a venture capital firm subsidiary of Morgan Stanley Investment Management Merchant Banking, which is ultimately owned by Morgan Stanley (NYSE: MWD) founded in 1986.The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
SANA BIOTECHNOLOGY, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
PANACEA ACQUISITION CORP. II | Financial Conglomerates | Director/Board Member | |
NEA Management Co. LLC
![]() NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
MINERVA SURGICAL, INC. | Medical Specialties | Director/Board Member | |
Ocutherix, Inc.
![]() Ocutherix, Inc. Medical SpecialtiesHealth Technology Ocutherix, Inc. operates as a medical device incubator which focuses on novel medical technologies. The firm serves the ophthalmology, cardiology, mobile health, orthopedics, neurology, pulmonology and metabolic clinical solutions. The company was founded by Robert E. Atkinson in 2005 and is headquartered in Stillwater, MN. | Medical Specialties | Director/Board Member | |
Rotation Medical, Inc.
![]() Rotation Medical, Inc. Medical SpecialtiesHealth Technology Rotation Medical, Inc. develops treatment of rotator cuff disease. It includes a bioinductive implant and a set of disposable arthroscopic instruments that has been shown to heal tendons by inducing the growth of new tendon-like tissue. The company was founded by Thomas R. Hektner in 2009 and is headquartered in Plymouth, MN. | Medical Specialties | Director/Board Member | |
Solace Therapeutics, Inc.
![]() Solace Therapeutics, Inc. Medical SpecialtiesHealth Technology Solace Therapeutics, Inc. develops non-surgical treatments for common bladder disorders. It offers medical devices for stress urinary incontinence, overactive bladder, male voiding dysfunction, and lower urinary tract symptoms. The company was founded by Kevin G. Connors in 2002 and is headquartered in Framingham, MA. | Medical Specialties | Director/Board Member | |
Adaptimmune Ltd.
![]() Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Cygnal Therapeutics, Inc.
![]() Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
NEVRO CORP. | Medical Specialties | Director/Board Member | |
CVRX, INC. | Medical Specialties | Director/Board Member |
Statistik
International
Vereinigte Staaten | 48 |
Schweiz | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 30 |
Consumer Services | 9 |
Finance | 7 |
Commercial Services | 4 |
Distribution Services | 2 |
Operativ
Director/Board Member | 147 |
Corporate Officer/Principal | 38 |
Independent Dir/Board Member | 38 |
Chief Executive Officer | 20 |
President | 12 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Michael Ross | 44 |
Ali Behbahani | 35 |
Rishi Gupta | 29 |
Douglas Williams | 25 |
Steven James | 24 |
Carlo Rizzuto | 22 |
Tony Kingsley | 14 |
Clare Ozawa | 14 |
William Grossman | 13 |
Christopher Dinsmore | 8 |
Kevin T. Sprott | 6 |
Alicia Levey | 5 |
Regina Salvat | 4 |
Brian Bowman | 1 |
Scott Kanner | 1 |
- Börse
- Insiders
- J.C. Lopez
- Unternehmensverbindungen